three kinds of antibiotics
PreclinicalSmall molecule
three kinds of antibiotics is one of 18 small molecule programs targeting Helicobacter Pylori Infection. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
17
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
30 competitors in Helicobacter Pylori Infection
#DrugCompanyPhaseTrials
1Biaxin
AbbVieApproved
Amoxil
GGlobal Antibiotics Research and Development Partnership
Approved
Flagyl
DDePuy Orthopaedics
Approved
Nexium
DDexcel Pharma Technologies Ltd.
Approved
Levaquin
WWim Janssens
Approved
Takecab
PPhathom Pharmaceuticals, Inc.
Approved
Achromycin V
WWyeth-Lederle Vaccines
Approved
Potassium Citrate
MMission Pharmacal
Approved
Tegoprazan
SShandong Luoxin Pharmaceutical Group Stock Co., Ltd.
Phase 3
Vonoprazan
TakedaPhase 3
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for three kinds of antibiotics. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- SShandong University